284 results
Page 5 of 15
424B5
f1olkn
29 Apr 20
Prospectus supplement for primary offering
5:23pm
S-3ASR
EX-4.1
vluuidcuydgbz3
29 Apr 20
Automatic shelf registration
5:18pm
S-3ASR
7kfot sz3
29 Apr 20
Automatic shelf registration
5:18pm
8-K
EX-99.1
0ga541fopv
28 Apr 20
NeoGenomics Reports 11% Revenue Growth to $106 Million
8:15am
8-K
EX-99.1
6jyoz6xge2f k3t
2 Mar 20
INVESTOR PRESENTATION February 2020
5:19pm
8-K
EX-99.1
cib84 6yzb
27 Feb 20
NeoGenomics Reports 40% Revenue Growth to $107 Million
8:09am
8-K
EX-2.1
p00v8 xkf
13 Jan 20
NeoGenomics Acquires Oncology Division from Human Longevity for $37 Million
4:50pm
8-K
EX-10.1
awslvu4oisn4
2 Dec 19
Departure of Directors or Certain Officers
5:07pm
8-K
EX-99.1
h8e6 odcj
31 Oct 19
INVESTOR PRESENTATION October 2019
12:00am
8-K
EX-99.1
ukra5se
29 Oct 19
NeoGenomics Reports 51% Revenue Growth to $105 Million
7:38am
8-K
EX-10.3
58efm29 dbw8
8 Aug 19
Departure of Directors or Certain Officers
7:16am
8-K
EX-10.2
c8u22em rpn5s5q7zfzo
8 Aug 19
Departure of Directors or Certain Officers
7:16am
8-K
EX-99.1
7xyq1fi
2 Aug 19
Regulation FD Disclosure
12:41pm